Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,354 public trials 2,837 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

NCT05936580

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • UT Health San Antonio San Antonio, Texas, United States
  • Helsinki University Hospital,Coagulation Disorder Unit Helsinki, Finland
  • Avenue de la République Chambray-lès-Tours, France
  • CHU de Nantes Hôtel-Dieu Nantes, France
View all 16 locations
View Trial Details
Recruiting

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

NCT06096116

Conditions
Acquired Antithrombin Deficiency, Antithrombin III Deficiency, Blood Coagulation Disorders, +7 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • University of Miami Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
View all 27 locations
View Trial Details
Recruiting

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

NCT05070845

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • East Carolina University Greenville, North Carolina, United States
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • South West Radiology Liverpool, New South Wales, Australia
  • Slade Pharmacy Mount Kuring-Gai, New South Wales, Australia
View all 31 locations
View Trial Details
Recruiting

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT06896916

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Beverly Hills Cancer Center /ID# 266921 Beverly Hills, California, United States
  • Colorado Blood Cancer Institute /ID# 273751 Denver, Colorado, United States
  • Washington University /ID# 266972 St Louis, Missouri, United States
  • Rutgers Cancer Institute of New Jersey /ID# 266833 New Brunswick, New Jersey, United States
View all 27 locations
View Trial Details
Recruiting

Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study

NCT05935358

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • UT Southwestern Medical Center Dallas, Texas, United States
  • University Hospital Centre Zagreb Zagreb, Croatia
  • Helsinki University Hospital Helsinki, Finland
  • CHU de Nantes Hôtel-Dieu Nantes, France
View all 18 locations
View Trial Details
Recruiting

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

NCT06290401

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +6 more
Locations
  • Nemours Children's Health Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Imaging Intravenous Iron

NCT05609318

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +7 more
Locations
  • Oxford Centre for Clinical Magnetic Resonance Research (OCMR) Oxford, Oxfordshire, United Kingdom
View Trial Details

Related conditions